Electrochemical and optical methods for detection of cystatin C as a biomarker of kidney disease

被引:0
|
作者
Zhang, Jiakui [1 ]
Ren, Baiping [2 ]
Liu, Jingxuan [3 ]
Li, Hongwu [4 ]
机构
[1] China Med Univ, Affiliated Hosp 4, Dept Surg Oncol, Shenyang 110032, Liaoning, Peoples R China
[2] Shangjing Hosp, Dept Urol, Chifeng 024000, Inner Mongolia, Peoples R China
[3] China Med Univ, Affiliated Hosp 4, Dept Urol, Shenyang 110032, Liaoning, Peoples R China
[4] China Med Univ, Dept Gen Surg, Affiliated Hosp 4, Shenyang 110032, Liaoning, Peoples R China
关键词
Chronic kidney disease; Cystatin C; Biomarker; Electrochemical biosensor; Optical biosensor; GLOMERULAR-FILTRATION-RATE; GAMMA-TRACE; SERUM; MARKER; IMMUNOASSAY; ASSAY; IMMUNOSENSOR; BIOSENSOR; SENSOR; ELISA;
D O I
10.1016/j.cbi.2024.111355
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The kidneys have vital functions in the body, including maintaining homeostasis and blood pressure, controlling water-electrolyte balance, and eliminating metabolic wastes. Early identification of renal dysfunction disease and selection of effective treatment methods reduce mortality in patients. Nowadays, Common indicators of kidney function lack the necessary specificity and sensitivity, but recent studies have reported that cystatin C (CysC) may be an ideal marker for glomerular filtration. CysC, known as a cysteine protease inhibitor, is synthesized by nucleated cells and is easily filtered due to its positive charge and low molecular weight. Also, the synthesis and secretion of CysC is a stable process that is not affected by dietary factors, enhanced protein catabolism, and renal conditions. Various studies have reported that measuring the level of CysC in the body's biological fluids is necessary for the treatment and diagnosis of a wide range of diseases, especially chronic kidney disease (CKD). Despite evidence that positive correlation between the high risk and/or progression of CKD and CysC, it's applied in clinical practice is still rare. Biosensors have been widely developed and researched as an effective method for the pharmaceutical, environmental, and medical fields. Biosensors are designed to create an effective electronic signal commensurate with the concentration of a particular biochemical.Recently, many studies have used biosensor techniques to detect CysC in kidneys and other diseases. In this study, we attempt to examine studies that have used different biosensor techniques for the detect CysC.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Urinary cystatin C as biomarker for identification of kidney disease in dogs
    Sivasakthi, R.
    Kumar, T. Satheesh
    Padmanath, K.
    Chandrasekar, M.
    Sriram, P.
    Pandiyan, V
    INDIAN JOURNAL OF ANIMAL RESEARCH, 2019, 53 (02) : 196 - 199
  • [2] Cystatin C as a biomarker of chronic kidney disease: latest developments
    Benoit, Stefanie W.
    Ciccia, Eileen A.
    Devarajan, Prasad
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (10) : 1019 - 1026
  • [3] Unlocking diagnostic potential: Advances in biosensing platforms for detection of cystatin C, a kidney disease biomarker
    Hosseini, Nashmin
    Nakhjavani, Sattar Akbari
    Ardalan, Mohammadreza
    Salimi, Abdollah
    Mirzajani, Hadi
    Adibkia, Khosro
    Omidi, Yadollah
    MICROCHEMICAL JOURNAL, 2025, 210
  • [4] Cystatin C: A Kidney Function Biomarker
    Onopiuk, Anna
    Tokarzewicz, Anna
    Gorodkiewicz, Ewa
    ADVANCES IN CLINICAL CHEMISTRY, VOL 68, 2015, 68 : 57 - 69
  • [5] Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats
    Ghys, L. F. E.
    Paepe, D.
    Lefebvre, H. P.
    Reynolds, B. S.
    Croubels, S.
    Meyer, E.
    Delanghe, J. R.
    Daminet, S.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2016, 30 (04) : 1074 - 1082
  • [6] Is Cystatin C a Useful Marker in the Detection of Diabetic Kidney Disease?
    Borges, Rodolfo L.
    Hirota, Andrea H.
    Quinto, Beata M. R.
    Ribeiro, Arthur B.
    Zanella, Maria T.
    Batista, Marcelo C.
    NEPHRON CLINICAL PRACTICE, 2010, 114 (02): : C127 - C134
  • [7] Cystatin C as a Diagnostic Biomarker for Chronic Kidney Disease in Frail Older Adults
    Kuroda, K.
    Birkland, A.
    Muniak, J. D.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 : S110 - S110
  • [8] Cystatin C: An Emerging Biomarker in Cardiovascular Disease
    Angelidis, Christos
    Deftereos, Spyridon
    Giannopoulos, Georgios
    Anatoliotakis, Nikolaos
    Bouras, Georgios
    Hatzis, Georgios
    Panagopoulou, Vasiliki
    Pyrgakis, Vlasios
    Cleman, Michael W.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (02) : 164 - 179
  • [9] Disposable electrochemical immunosensor for analysis of cystatin C, a CKD biomarker
    Lopes, Paula
    Costa-Rama, Estefania
    Beirao, Idalina
    Nouws, Henri P. A.
    Santos-Silva, Alice
    Delerue-Matos, Cristina
    TALANTA, 2019, 201 : 211 - 216
  • [10] Cystatin c as a new biomarker in patients with chronic kidney disease: A review and meta-analysis
    Bao L.
    Zhou Q.
    Lin Y.
    Lin X.
    Hu Q.
    Bao, Lingxin (bolingxmu@sina.com), 1600, Science Publications (17): : 328 - 337